BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 10077418)

  • 1. Analysis of the humoral immune response against total and recombinant antigens of Leishmania infantum: correlation with disease progression in canine experimental leishmaniasis.
    Nieto CG; García-Alonso M; Requena JM; Mirón C; Soto M; Alonso C; Navarrete I
    Vet Immunol Immunopathol; 1999 Feb; 67(2):117-30. PubMed ID: 10077418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of the Leishmania infantum-specific antibody repertoires and the autoantibody repertoires between asymptomatic and symptomatic dogs.
    Chaabouni A; Boubaker Elandoulsi R; Mhadhbi M; Gharbi M; Sassi A
    Vet Parasitol; 2018 Sep; 261():9-17. PubMed ID: 30253856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell mediated immunity and specific IgG1 and IgG2 antibody response in natural and experimental canine leishmaniosis.
    Leandro C; Santos-Gomes GM; Campino L; Romão P; Cortes S; Rolão N; Gomes-Pereira S; Riça Capela MJ; Abranches P
    Vet Immunol Immunopathol; 2001 May; 79(3-4):273-84. PubMed ID: 11389961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of antibodies to Leishmania silent information regulatory 2 (SIR2) protein homologue during canine natural infections: pathological implications.
    Cordeiro-da-Silva A; Cardoso L; Araújo N; Castro H; Tomás A; Rodrigues M; Cabral M; Vergnes B; Sereno D; Ouaissi A
    Immunol Lett; 2003 Apr; 86(2):155-62. PubMed ID: 12644317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
    Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
    Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes.
    Lemesre JL; Holzmuller P; Cavaleyra M; Gonçalves RB; Hottin G; Papierok G
    Vaccine; 2005 Apr; 23(22):2825-40. PubMed ID: 15780731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological evaluation of experimentally infected dogs by LicTXNPx-ELISA and amastigote-flow cytometry.
    Silvestre R; Santarém N; Cunha J; Cardoso L; Nieto J; Carrillo E; Moreno J; Cordeiro-da-Silva A
    Vet Parasitol; 2008 Nov; 158(1-2):23-30. PubMed ID: 18848397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant Forms of Leishmania amazonensis Excreted/Secreted Promastigote Surface Antigen (PSA) Induce Protective Immune Responses in Dogs.
    Petitdidier E; Pagniez J; Papierok G; Vincendeau P; Lemesre JL; Bras-Gonçalves R
    PLoS Negl Trop Dis; 2016 May; 10(5):e0004614. PubMed ID: 27223609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral and cell-mediated immunity in natural and experimental canine leishmaniasis.
    Martínez-Moreno A; Moreno T; Martínez-Moreno FJ; Acosta I; Hernández S
    Vet Immunol Immunopathol; 1995 Oct; 48(3-4):209-20. PubMed ID: 8578681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leishmania infantum-specific IgG, IgG1 and IgG2 antibody responses in healthy and ill dogs from endemic areas. Evolution in the course of infection and after treatment.
    Solano-Gallego L; Riera C; Roura X; Iniesta L; Gallego M; Valladares JE; Fisa R; Castillejo S; Alberola J; Ferrer L; Arboix M; Portús M
    Vet Parasitol; 2001 Apr; 96(4):265-76. PubMed ID: 11267753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of new Leishmania promastigote surface antigens, LaPSA-38S and LiPSA-50S, as major immunodominant excreted/secreted components of L. amazonensis and L. infantum.
    Bras-Gonçalves R; Petitdidier E; Pagniez J; Veyrier R; Cibrelus P; Cavaleyra M; Maquaire S; Moreaux J; Lemesre JL
    Infect Genet Evol; 2014 Jun; 24():1-14. PubMed ID: 24614507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune response against Leishmania antigens in dogs naturally and experimentally infected with Leishmania infantum.
    Rhalem A; Sahibi H; Guessous-Idrissi N; Lasri S; Natami A; Riyad M; Berrag B
    Vet Parasitol; 1999 Mar; 81(3):173-84. PubMed ID: 10190861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody response in dogs experimentally infected with Leishmania infantum: infection course antigen markers.
    Carrera L; Fermín ML; Tesouro M; García P; Rollán E; González JL; Méndez S; Cuquerella M; Alunda JM
    Exp Parasitol; 1996 Mar; 82(2):139-46. PubMed ID: 8617340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Leishmania infantum multi-component antigenic protein mixed with live BCG confers protection to dogs experimentally infected with L. infantum.
    Molano I; Alonso MG; Mirón C; Redondo E; Requena JM; Soto M; Nieto CG; Alonso C
    Vet Immunol Immunopathol; 2003 Mar; 92(1-2):1-13. PubMed ID: 12628759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humoral and cellular immune responses against Type I cysteine proteinase of Leishmania infantum are higher in asymptomatic than symptomatic dogs selected from a naturally infected population.
    Nakhaee A; Taheri T; Taghikhani M; Mohebali M; Salmanian AH; Fasel N; Rafati S
    Vet Parasitol; 2004 Jan; 119(2-3):107-23. PubMed ID: 14746971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An immunoproteomic approach to identifying immunoreactive proteins in
    Rashidi S; Mojtahedi Z; Shahriari B; Kalantar K; Ghalamfarsa G; Mohebali M; Hatam G
    Pathog Glob Health; 2019 May; 113(3):124-132. PubMed ID: 31099725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics and diagnostic and prognostic potential of quantitative Western blot analysis and antigen-specific enzyme-linked immunosorbent assay in experimental canine leishmaniasis.
    Talmi-Frank D; Strauss-Ayali D; Jaffe CL; Baneth G
    Clin Vaccine Immunol; 2006 Feb; 13(2):271-6. PubMed ID: 16467337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early antibody response and clinical outcome in experimental canine leishmaniasis.
    Olías-Molero AI; Corral MJ; Jiménez-Antón MD; Alunda JM
    Sci Rep; 2019 Dec; 9(1):18606. PubMed ID: 31819140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships between specific antibody responses and clinical signs of dogs living in Tunisian endemic areas of canine leishmaniasis caused by Leishmania infantum.
    Mhadhbi M; Chaabouni A; Bouabid C; Sassi A
    Acta Trop; 2021 Jun; 218():105906. PubMed ID: 33775627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental model for reproduction of canine visceral leishmaniosis by Leishmania infantum.
    Fernández-Cotrina J; Iniesta V; Belinchón-Lorenzo S; Muñoz-Madrid R; Serrano F; Parejo JC; Gómez-Gordo L; Soto M; Alonso C; Gómez-Nieto LC
    Vet Parasitol; 2013 Feb; 192(1-3):118-28. PubMed ID: 23102507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.